Heartflow, Inc.

HTFL Healthcare Health Information Services

Heartflow, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $176.0 million, up 39.9% from fiscal 2024. In the quarter to June 2026, revenue grew 47.6%, EPS grew 87.7% and free cash flow grew 62.6%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

48.29 2.62 −5.15%
Market cap
$4.4B
P/E
0.0×
Fwd P/E
−37.5×
Dividend yield
—
F-score
5/9
Altman Z
7.22
Beneish M
−2.55
Dividend safety
n/a

Heartflow, Inc. (HTFL) P/E ratio

Alert me on P/E ratio

Heartflow, Inc. has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (October 2026) to 0.0× (October 2026) — the current reading is the highest in ten years.

P/E ratio, daily

Embed this chart

Annual newest first

Period P/E ratio Change
FY2025 0.0× —
FY2024 0.0× —
FY2023 0.0× —

Quarterly newest first

Period P/E ratio Change
Jun 2026 0.0× —
Mar 2026 0.0× —
Dec 2025 0.0× —
Sep 2025 0.0× —
6 more quarters

Against its own ten years

Low 0.0× High 0.0×
Ten-year median 0.0×
Current reading's percentile 100

P/E ratio against peers

Company P/E ratio
HTFL Heartflow, Inc. n/m
TXG 10x Genomics compare n/m
SDGR Schrodinger, Inc. compare n/m
HQY HealthEquity, Inc. compare 33.0×
DOCS Doximity, Inc. compare 34.8×
WAY Waystar Holding Corp. compare 38.0×
OMCL Omnicell, Inc. compare 41.6×
HNGE Hinge Health Inc. compare 73.5×
PRVA Privia Health Group, Inc. compare 102×
Health Information Services industry median 39.8×
Healthcare sector median 23.0×
Market median 18.1×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

More on HTFL